CN Patent

CN102471328B — 吡啶-4-基衍生物

Assigned to Huizhi Asia Pacific Private Ltd · Expires 2015-04-01 · 11y expired

What this patent protects

本发明涉及如下式(I)的吡啶衍生物，其中A、R 1 、R 2 、R 3 及R 4 是如说明书中所述，其制剂及其作为医药活性化合物的用途。所述化合物尤其具有作为免疫调节剂的作用。

USPTO Abstract

本发明涉及如下式(I)的吡啶衍生物，其中A、R 1 、R 2 、R 3 及R 4 是如说明书中所述，其制剂及其作为医药活性化合物的用途。所述化合物尤其具有作为免疫调节剂的作用。

Drugs covered by this patent

ozanimod-hydrochloride (OZANIMOD HYDROCHLORIDE)

Patent Metadata

Patent number: CN102471328B
Jurisdiction: CN
Classification: —
Expires: 2015-04-01
Drug substance claim: No
Drug product claim: No
Assignee: Huizhi Asia Pacific Private Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.